It is estimated that, to put a new drug on the market, are required more than $2B and 10-12 years in R&D. More than 80% of drugs that look promising in animal models fail when tested in humans.
TToP is a modular, versatile, and user-friendly MicroPhysiolgical platform that guarantees more predictive results than conventional cell culture technologies, replicating complex human pathophysiological conditions, minimizing the controversial animal use in research.
True Tissue On Platform is based on a cartridge-based design suitable for well-established studies and for cutting-edge culture methodologies.
The patented technology enables the controlled management of the biological sample, allowing to retrieve it without damages to perform end-point analysis or to reuse it, designing sequential treatments.
TToP versatily allow to host multiple types of biological samples.
versatily allow to host multiple types of biological samples.